Medical Care

Global Self-Amplifying RNA In Vitro Synthesis Service Market Research Report 2025

The global market for Self-Amplifying RNA In Vitro Synthesis Service was valued at US$ 1269 million in the year 2024 and is projected to reach a revised size of US$ 2521 million by 2031, growing at a CAGR of 10.5% during the forecast period.
Self-amplifying RNA (saRNA) is a modified form of mRNA that possesses the ability to self-replicate. Unlike traditional mRNA that typically encodes a single protein, saRNA takes it a step further by carrying not only the genetic instructions for a specific protein but also the machinery required for its own replication. This unique characteristic allows saRNA to exponentially amplify the production of protein-encoding RNA within cells, making it a powerful tool for various applications such as gene therapy, vaccine development, and protein production.
North American market for Self-Amplifying RNA In Vitro Synthesis Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Self-Amplifying RNA In Vitro Synthesis Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Self-Amplifying RNA In Vitro Synthesis Service in Drug Discovery is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Self-Amplifying RNA In Vitro Synthesis Service include GenScript, Hongene Biotech, VectorBuilder, Novoprotein, Creative Biolabs, OZ Biosciences, Creative Biogene, BOC Sciences, Croyez, uBriGene, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Self-Amplifying RNA In Vitro Synthesis Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Self-Amplifying RNA In Vitro Synthesis Service.
The Self-Amplifying RNA In Vitro Synthesis Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Self-Amplifying RNA In Vitro Synthesis Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Self-Amplifying RNA In Vitro Synthesis Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GenScript
Hongene Biotech
VectorBuilder
Novoprotein
Creative Biolabs
OZ Biosciences
Creative Biogene
BOC Sciences
Croyez
uBriGene
Segment by Type
Research Grade
GMP Grade
Segment by Application
Drug Discovery
Cell Therapy
Vaccine R&D
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Self-Amplifying RNA In Vitro Synthesis Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Self-Amplifying RNA In Vitro Synthesis Service Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Research Grade
1.2.3 GMP Grade
1.3 Market by Application
1.3.1 Global Self-Amplifying RNA In Vitro Synthesis Service Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Drug Discovery
1.3.3 Cell Therapy
1.3.4 Vaccine R&D
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Self-Amplifying RNA In Vitro Synthesis Service Market Perspective (2020-2031)
2.2 Global Self-Amplifying RNA In Vitro Synthesis Service Growth Trends by Region
2.2.1 Global Self-Amplifying RNA In Vitro Synthesis Service Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Self-Amplifying RNA In Vitro Synthesis Service Historic Market Size by Region (2020-2025)
2.2.3 Self-Amplifying RNA In Vitro Synthesis Service Forecasted Market Size by Region (2026-2031)
2.3 Self-Amplifying RNA In Vitro Synthesis Service Market Dynamics
2.3.1 Self-Amplifying RNA In Vitro Synthesis Service Industry Trends
2.3.2 Self-Amplifying RNA In Vitro Synthesis Service Market Drivers
2.3.3 Self-Amplifying RNA In Vitro Synthesis Service Market Challenges
2.3.4 Self-Amplifying RNA In Vitro Synthesis Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Self-Amplifying RNA In Vitro Synthesis Service Players by Revenue
3.1.1 Global Top Self-Amplifying RNA In Vitro Synthesis Service Players by Revenue (2020-2025)
3.1.2 Global Self-Amplifying RNA In Vitro Synthesis Service Revenue Market Share by Players (2020-2025)
3.2 Global Top Self-Amplifying RNA In Vitro Synthesis Service Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Self-Amplifying RNA In Vitro Synthesis Service Revenue
3.4 Global Self-Amplifying RNA In Vitro Synthesis Service Market Concentration Ratio
3.4.1 Global Self-Amplifying RNA In Vitro Synthesis Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Self-Amplifying RNA In Vitro Synthesis Service Revenue in 2024
3.5 Global Key Players of Self-Amplifying RNA In Vitro Synthesis Service Head office and Area Served
3.6 Global Key Players of Self-Amplifying RNA In Vitro Synthesis Service, Product and Application
3.7 Global Key Players of Self-Amplifying RNA In Vitro Synthesis Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Self-Amplifying RNA In Vitro Synthesis Service Breakdown Data by Type
4.1 Global Self-Amplifying RNA In Vitro Synthesis Service Historic Market Size by Type (2020-2025)
4.2 Global Self-Amplifying RNA In Vitro Synthesis Service Forecasted Market Size by Type (2026-2031)
5 Self-Amplifying RNA In Vitro Synthesis Service Breakdown Data by Application
5.1 Global Self-Amplifying RNA In Vitro Synthesis Service Historic Market Size by Application (2020-2025)
5.2 Global Self-Amplifying RNA In Vitro Synthesis Service Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Self-Amplifying RNA In Vitro Synthesis Service Market Size (2020-2031)
6.2 North America Self-Amplifying RNA In Vitro Synthesis Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Self-Amplifying RNA In Vitro Synthesis Service Market Size by Country (2020-2025)
6.4 North America Self-Amplifying RNA In Vitro Synthesis Service Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Self-Amplifying RNA In Vitro Synthesis Service Market Size (2020-2031)
7.2 Europe Self-Amplifying RNA In Vitro Synthesis Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Self-Amplifying RNA In Vitro Synthesis Service Market Size by Country (2020-2025)
7.4 Europe Self-Amplifying RNA In Vitro Synthesis Service Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Self-Amplifying RNA In Vitro Synthesis Service Market Size (2020-2031)
8.2 Asia-Pacific Self-Amplifying RNA In Vitro Synthesis Service Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Self-Amplifying RNA In Vitro Synthesis Service Market Size by Region (2020-2025)
8.4 Asia-Pacific Self-Amplifying RNA In Vitro Synthesis Service Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Self-Amplifying RNA In Vitro Synthesis Service Market Size (2020-2031)
9.2 Latin America Self-Amplifying RNA In Vitro Synthesis Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Self-Amplifying RNA In Vitro Synthesis Service Market Size by Country (2020-2025)
9.4 Latin America Self-Amplifying RNA In Vitro Synthesis Service Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Self-Amplifying RNA In Vitro Synthesis Service Market Size (2020-2031)
10.2 Middle East & Africa Self-Amplifying RNA In Vitro Synthesis Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Self-Amplifying RNA In Vitro Synthesis Service Market Size by Country (2020-2025)
10.4 Middle East & Africa Self-Amplifying RNA In Vitro Synthesis Service Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GenScript
11.1.1 GenScript Company Details
11.1.2 GenScript Business Overview
11.1.3 GenScript Self-Amplifying RNA In Vitro Synthesis Service Introduction
11.1.4 GenScript Revenue in Self-Amplifying RNA In Vitro Synthesis Service Business (2020-2025)
11.1.5 GenScript Recent Development
11.2 Hongene Biotech
11.2.1 Hongene Biotech Company Details
11.2.2 Hongene Biotech Business Overview
11.2.3 Hongene Biotech Self-Amplifying RNA In Vitro Synthesis Service Introduction
11.2.4 Hongene Biotech Revenue in Self-Amplifying RNA In Vitro Synthesis Service Business (2020-2025)
11.2.5 Hongene Biotech Recent Development
11.3 VectorBuilder
11.3.1 VectorBuilder Company Details
11.3.2 VectorBuilder Business Overview
11.3.3 VectorBuilder Self-Amplifying RNA In Vitro Synthesis Service Introduction
11.3.4 VectorBuilder Revenue in Self-Amplifying RNA In Vitro Synthesis Service Business (2020-2025)
11.3.5 VectorBuilder Recent Development
11.4 Novoprotein
11.4.1 Novoprotein Company Details
11.4.2 Novoprotein Business Overview
11.4.3 Novoprotein Self-Amplifying RNA In Vitro Synthesis Service Introduction
11.4.4 Novoprotein Revenue in Self-Amplifying RNA In Vitro Synthesis Service Business (2020-2025)
11.4.5 Novoprotein Recent Development
11.5 Creative Biolabs
11.5.1 Creative Biolabs Company Details
11.5.2 Creative Biolabs Business Overview
11.5.3 Creative Biolabs Self-Amplifying RNA In Vitro Synthesis Service Introduction
11.5.4 Creative Biolabs Revenue in Self-Amplifying RNA In Vitro Synthesis Service Business (2020-2025)
11.5.5 Creative Biolabs Recent Development
11.6 OZ Biosciences
11.6.1 OZ Biosciences Company Details
11.6.2 OZ Biosciences Business Overview
11.6.3 OZ Biosciences Self-Amplifying RNA In Vitro Synthesis Service Introduction
11.6.4 OZ Biosciences Revenue in Self-Amplifying RNA In Vitro Synthesis Service Business (2020-2025)
11.6.5 OZ Biosciences Recent Development
11.7 Creative Biogene
11.7.1 Creative Biogene Company Details
11.7.2 Creative Biogene Business Overview
11.7.3 Creative Biogene Self-Amplifying RNA In Vitro Synthesis Service Introduction
11.7.4 Creative Biogene Revenue in Self-Amplifying RNA In Vitro Synthesis Service Business (2020-2025)
11.7.5 Creative Biogene Recent Development
11.8 BOC Sciences
11.8.1 BOC Sciences Company Details
11.8.2 BOC Sciences Business Overview
11.8.3 BOC Sciences Self-Amplifying RNA In Vitro Synthesis Service Introduction
11.8.4 BOC Sciences Revenue in Self-Amplifying RNA In Vitro Synthesis Service Business (2020-2025)
11.8.5 BOC Sciences Recent Development
11.9 Croyez
11.9.1 Croyez Company Details
11.9.2 Croyez Business Overview
11.9.3 Croyez Self-Amplifying RNA In Vitro Synthesis Service Introduction
11.9.4 Croyez Revenue in Self-Amplifying RNA In Vitro Synthesis Service Business (2020-2025)
11.9.5 Croyez Recent Development
11.10 uBriGene
11.10.1 uBriGene Company Details
11.10.2 uBriGene Business Overview
11.10.3 uBriGene Self-Amplifying RNA In Vitro Synthesis Service Introduction
11.10.4 uBriGene Revenue in Self-Amplifying RNA In Vitro Synthesis Service Business (2020-2025)
11.10.5 uBriGene Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Self-Amplifying RNA In Vitro Synthesis Service Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Research Grade
Table 3. Key Players of GMP Grade
Table 4. Global Self-Amplifying RNA In Vitro Synthesis Service Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Self-Amplifying RNA In Vitro Synthesis Service Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Self-Amplifying RNA In Vitro Synthesis Service Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Self-Amplifying RNA In Vitro Synthesis Service Market Share by Region (2020-2025)
Table 8. Global Self-Amplifying RNA In Vitro Synthesis Service Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Self-Amplifying RNA In Vitro Synthesis Service Market Share by Region (2026-2031)
Table 10. Self-Amplifying RNA In Vitro Synthesis Service Market Trends
Table 11. Self-Amplifying RNA In Vitro Synthesis Service Market Drivers
Table 12. Self-Amplifying RNA In Vitro Synthesis Service Market Challenges
Table 13. Self-Amplifying RNA In Vitro Synthesis Service Market Restraints
Table 14. Global Self-Amplifying RNA In Vitro Synthesis Service Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Self-Amplifying RNA In Vitro Synthesis Service Market Share by Players (2020-2025)
Table 16. Global Top Self-Amplifying RNA In Vitro Synthesis Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Self-Amplifying RNA In Vitro Synthesis Service as of 2024)
Table 17. Ranking of Global Top Self-Amplifying RNA In Vitro Synthesis Service Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Self-Amplifying RNA In Vitro Synthesis Service Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Self-Amplifying RNA In Vitro Synthesis Service, Headquarters and Area Served
Table 20. Global Key Players of Self-Amplifying RNA In Vitro Synthesis Service, Product and Application
Table 21. Global Key Players of Self-Amplifying RNA In Vitro Synthesis Service, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Self-Amplifying RNA In Vitro Synthesis Service Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Self-Amplifying RNA In Vitro Synthesis Service Revenue Market Share by Type (2020-2025)
Table 25. Global Self-Amplifying RNA In Vitro Synthesis Service Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Self-Amplifying RNA In Vitro Synthesis Service Revenue Market Share by Type (2026-2031)
Table 27. Global Self-Amplifying RNA In Vitro Synthesis Service Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Self-Amplifying RNA In Vitro Synthesis Service Revenue Market Share by Application (2020-2025)
Table 29. Global Self-Amplifying RNA In Vitro Synthesis Service Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Self-Amplifying RNA In Vitro Synthesis Service Revenue Market Share by Application (2026-2031)
Table 31. North America Self-Amplifying RNA In Vitro Synthesis Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Self-Amplifying RNA In Vitro Synthesis Service Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Self-Amplifying RNA In Vitro Synthesis Service Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Self-Amplifying RNA In Vitro Synthesis Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Self-Amplifying RNA In Vitro Synthesis Service Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Self-Amplifying RNA In Vitro Synthesis Service Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Self-Amplifying RNA In Vitro Synthesis Service Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Self-Amplifying RNA In Vitro Synthesis Service Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Self-Amplifying RNA In Vitro Synthesis Service Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Self-Amplifying RNA In Vitro Synthesis Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Self-Amplifying RNA In Vitro Synthesis Service Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Self-Amplifying RNA In Vitro Synthesis Service Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Self-Amplifying RNA In Vitro Synthesis Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Self-Amplifying RNA In Vitro Synthesis Service Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Self-Amplifying RNA In Vitro Synthesis Service Market Size by Country (2026-2031) & (US$ Million)
Table 46. GenScript Company Details
Table 47. GenScript Business Overview
Table 48. GenScript Self-Amplifying RNA In Vitro Synthesis Service Product
Table 49. GenScript Revenue in Self-Amplifying RNA In Vitro Synthesis Service Business (2020-2025) & (US$ Million)
Table 50. GenScript Recent Development
Table 51. Hongene Biotech Company Details
Table 52. Hongene Biotech Business Overview
Table 53. Hongene Biotech Self-Amplifying RNA In Vitro Synthesis Service Product
Table 54. Hongene Biotech Revenue in Self-Amplifying RNA In Vitro Synthesis Service Business (2020-2025) & (US$ Million)
Table 55. Hongene Biotech Recent Development
Table 56. VectorBuilder Company Details
Table 57. VectorBuilder Business Overview
Table 58. VectorBuilder Self-Amplifying RNA In Vitro Synthesis Service Product
Table 59. VectorBuilder Revenue in Self-Amplifying RNA In Vitro Synthesis Service Business (2020-2025) & (US$ Million)
Table 60. VectorBuilder Recent Development
Table 61. Novoprotein Company Details
Table 62. Novoprotein Business Overview
Table 63. Novoprotein Self-Amplifying RNA In Vitro Synthesis Service Product
Table 64. Novoprotein Revenue in Self-Amplifying RNA In Vitro Synthesis Service Business (2020-2025) & (US$ Million)
Table 65. Novoprotein Recent Development
Table 66. Creative Biolabs Company Details
Table 67. Creative Biolabs Business Overview
Table 68. Creative Biolabs Self-Amplifying RNA In Vitro Synthesis Service Product
Table 69. Creative Biolabs Revenue in Self-Amplifying RNA In Vitro Synthesis Service Business (2020-2025) & (US$ Million)
Table 70. Creative Biolabs Recent Development
Table 71. OZ Biosciences Company Details
Table 72. OZ Biosciences Business Overview
Table 73. OZ Biosciences Self-Amplifying RNA In Vitro Synthesis Service Product
Table 74. OZ Biosciences Revenue in Self-Amplifying RNA In Vitro Synthesis Service Business (2020-2025) & (US$ Million)
Table 75. OZ Biosciences Recent Development
Table 76. Creative Biogene Company Details
Table 77. Creative Biogene Business Overview
Table 78. Creative Biogene Self-Amplifying RNA In Vitro Synthesis Service Product
Table 79. Creative Biogene Revenue in Self-Amplifying RNA In Vitro Synthesis Service Business (2020-2025) & (US$ Million)
Table 80. Creative Biogene Recent Development
Table 81. BOC Sciences Company Details
Table 82. BOC Sciences Business Overview
Table 83. BOC Sciences Self-Amplifying RNA In Vitro Synthesis Service Product
Table 84. BOC Sciences Revenue in Self-Amplifying RNA In Vitro Synthesis Service Business (2020-2025) & (US$ Million)
Table 85. BOC Sciences Recent Development
Table 86. Croyez Company Details
Table 87. Croyez Business Overview
Table 88. Croyez Self-Amplifying RNA In Vitro Synthesis Service Product
Table 89. Croyez Revenue in Self-Amplifying RNA In Vitro Synthesis Service Business (2020-2025) & (US$ Million)
Table 90. Croyez Recent Development
Table 91. uBriGene Company Details
Table 92. uBriGene Business Overview
Table 93. uBriGene Self-Amplifying RNA In Vitro Synthesis Service Product
Table 94. uBriGene Revenue in Self-Amplifying RNA In Vitro Synthesis Service Business (2020-2025) & (US$ Million)
Table 95. uBriGene Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
Table 99. Authors List of This Report


List of Figures
Figure 1. Self-Amplifying RNA In Vitro Synthesis Service Picture
Figure 2. Global Self-Amplifying RNA In Vitro Synthesis Service Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Self-Amplifying RNA In Vitro Synthesis Service Market Share by Type: 2024 VS 2031
Figure 4. Research Grade Features
Figure 5. GMP Grade Features
Figure 6. Global Self-Amplifying RNA In Vitro Synthesis Service Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Self-Amplifying RNA In Vitro Synthesis Service Market Share by Application: 2024 VS 2031
Figure 8. Drug Discovery Case Studies
Figure 9. Cell Therapy Case Studies
Figure 10. Vaccine R&D Case Studies
Figure 11. Other Case Studies
Figure 12. Self-Amplifying RNA In Vitro Synthesis Service Report Years Considered
Figure 13. Global Self-Amplifying RNA In Vitro Synthesis Service Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Self-Amplifying RNA In Vitro Synthesis Service Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Self-Amplifying RNA In Vitro Synthesis Service Market Share by Region: 2024 VS 2031
Figure 16. Global Self-Amplifying RNA In Vitro Synthesis Service Market Share by Players in 2024
Figure 17. Global Self-Amplifying RNA In Vitro Synthesis Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 18. The Top 10 and 5 Players Market Share by Self-Amplifying RNA In Vitro Synthesis Service Revenue in 2024
Figure 19. North America Self-Amplifying RNA In Vitro Synthesis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Self-Amplifying RNA In Vitro Synthesis Service Market Share by Country (2020-2031)
Figure 21. United States Self-Amplifying RNA In Vitro Synthesis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Self-Amplifying RNA In Vitro Synthesis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Self-Amplifying RNA In Vitro Synthesis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Self-Amplifying RNA In Vitro Synthesis Service Market Share by Country (2020-2031)
Figure 25. Germany Self-Amplifying RNA In Vitro Synthesis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Self-Amplifying RNA In Vitro Synthesis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Self-Amplifying RNA In Vitro Synthesis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Self-Amplifying RNA In Vitro Synthesis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Self-Amplifying RNA In Vitro Synthesis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Self-Amplifying RNA In Vitro Synthesis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Self-Amplifying RNA In Vitro Synthesis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Self-Amplifying RNA In Vitro Synthesis Service Market Share by Region (2020-2031)
Figure 33. China Self-Amplifying RNA In Vitro Synthesis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Self-Amplifying RNA In Vitro Synthesis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Self-Amplifying RNA In Vitro Synthesis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Self-Amplifying RNA In Vitro Synthesis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Self-Amplifying RNA In Vitro Synthesis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Self-Amplifying RNA In Vitro Synthesis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Self-Amplifying RNA In Vitro Synthesis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Self-Amplifying RNA In Vitro Synthesis Service Market Share by Country (2020-2031)
Figure 41. Mexico Self-Amplifying RNA In Vitro Synthesis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Self-Amplifying RNA In Vitro Synthesis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Self-Amplifying RNA In Vitro Synthesis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Self-Amplifying RNA In Vitro Synthesis Service Market Share by Country (2020-2031)
Figure 45. Turkey Self-Amplifying RNA In Vitro Synthesis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Self-Amplifying RNA In Vitro Synthesis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Self-Amplifying RNA In Vitro Synthesis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. GenScript Revenue Growth Rate in Self-Amplifying RNA In Vitro Synthesis Service Business (2020-2025)
Figure 49. Hongene Biotech Revenue Growth Rate in Self-Amplifying RNA In Vitro Synthesis Service Business (2020-2025)
Figure 50. VectorBuilder Revenue Growth Rate in Self-Amplifying RNA In Vitro Synthesis Service Business (2020-2025)
Figure 51. Novoprotein Revenue Growth Rate in Self-Amplifying RNA In Vitro Synthesis Service Business (2020-2025)
Figure 52. Creative Biolabs Revenue Growth Rate in Self-Amplifying RNA In Vitro Synthesis Service Business (2020-2025)
Figure 53. OZ Biosciences Revenue Growth Rate in Self-Amplifying RNA In Vitro Synthesis Service Business (2020-2025)
Figure 54. Creative Biogene Revenue Growth Rate in Self-Amplifying RNA In Vitro Synthesis Service Business (2020-2025)
Figure 55. BOC Sciences Revenue Growth Rate in Self-Amplifying RNA In Vitro Synthesis Service Business (2020-2025)
Figure 56. Croyez Revenue Growth Rate in Self-Amplifying RNA In Vitro Synthesis Service Business (2020-2025)
Figure 57. uBriGene Revenue Growth Rate in Self-Amplifying RNA In Vitro Synthesis Service Business (2020-2025)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies